Lannett Co Inc (LCIN) 8-K Bankruptcy or Receivership, Financial Obligation Increase, Regulated Disclosure

LCIN Corporate News

Bankruptcy or Receivership
Financial Exhibit
Financial Obligation Increase
Regulated Disclosure

May 2023

Ending Agreement
Financial Exhibit
Regulated Disclosure

May 2023

Event for Officers
Financial Exhibit
New Agreement
Regulated Disclosure

May 2023

Lannett Co Inc

HISTORY TOOLS

CIK: 97148 Ticker: LCIN

Please wait while we load the requested 8-K report or click the link below:

https://last10k.com/sec-filings/report/57725/000110465923055287/tm2314233d3_8k.htm

View differences made from one to another to evaluate Lannett Co Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ) — *Sample 10-K Year-over-Year (YoY) Comparison*

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were ~~removed~~ , added and changed by Lannett Co Inc.

Continue

Assess how Lannett Co Inc's management team is paid from their Annual Proxy

Lannett Co Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2023 10-K Annual Report includes:

Voting Procedures
Board Members
Executive Team
Salaries, Bonuses, Perks
Peers / Competitors

Continue

Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Material Contracts, Statements, Certifications & more

Lannett Co Inc provided additional information to their SEC Filing as exhibits

Exhibit 99.1: Additional Exhibits

Ticker: LCIN
CIK: 57725
Form Type: 8-K Corporate News
Accession Number: 0001104659-23-055287
Submitted to the SEC: Wed May 03 2023 8:40:28 AM EST
Accepted by the SEC: Wed May 03 2023
Period: Tuesday, May 2, 2023
Industry: Pharmaceutical Preparations